Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Foliglurax

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lundbeck adds a Parkinson's flop to its list , writing off a $1.1 billion deal
    Lundbeck adds a Parkinson's flop to its list , writing off a $1.1 billion deal

    31 Mar 2020

    // John Carroll ENDPTS

    https://endpts.com/lundbeck-adds-a-parkinsons-flop-to-its-list-of-setbacks-writing-off-a-1-1-billion-deal-on-mid-stage-failure/

    John Carroll ENDPTS
    31 Mar 2020
    Share Share
    Lundbeck To Acquire Prexton Therapeutics
    Lundbeck To Acquire Prexton Therapeutics

    18 Mar 2018

    // GLOBENEWSWIRE

    https://globenewswire.com/news-release/2018/03/16/1441274/0/en/Lundbeck-to-acquire-Prexton-Therapeutics-adding-foliglurax-in-clinical-phase-II-to-its-pipeline-of-innovative-treatments-for-patients-suffering-from-Parkinson-s-disease.html

    GLOBENEWSWIRE
    18 Mar 2018
    Share Share